FMED ETF
Fidelity Disruptive Medicine ETF
FMED ETF Overview
FMED ETF (Fidelity Disruptive Medicine ETF) is managed by Fidelity Investments (US) with $52.3M in net assets. FMED expense ratio is 0.50%, holding 144 positions across sectors including Health Care, Information Technology, Financials. Inception date: 2023-02-13.
FMED performance shows a YTD return of 19.64%. The 1-year return is 28.70% and the 5-year return is -1.62%.
FMED top holdings include NET OTHER ASSETS (13.4%), Fidelity Securities Lending Cash Central Fund (13.4%), 10x Genomics Inc Com Usd 1 Cl A (5.8%), Natera Inc (4.4%), Thermo Fisher Scientific Inc (4.1%). Go to all FMED holdings, FMED sectors, or FMED dividends.
FMED can be compared against other funds. Use FMED overlap to find shared positions, or FMED vs another fund for a side-by-side view. FMED alternatives are available via the screener, along with tax-loss harvesting opportunities.